Europa Capital, the pan-European real estate investment manager, together with its joint venture partner, Balzac REIM, announces the sale of Sémaphore, a fully let 12,000 sq m office building in Levallois-Perret, to the north west of central Paris, on behalf of its value add fund, Europa Fund V (the “Fund”), to one of the funds of Primonial REIM, for €142.5m.
The sale follows shortly after the agreement of a nine-year firm lease for the entirety of the eight-storey building, whilst it was being refurbished, with Doctolib, a high-profile French technology company which in recent years has developed a leading online medical appointment booking platform. Doctolib will take occupation of the asset in January 2020.
Europa Capital and Balzac REIM acquired the property with vacant possession in 2017, and having obtained revisions to an existing construction permit, undertook a comprehensive refurbishment of the building. This included the creation of a new staff restaurant and cafeteria, the installation of a new heating and cooling system, as well as the re-landscaping of the roof terraces and internal courtyard. As a result, the building has been awarded HQE Renovation ‘Excellent’ and is targeting a BREEAM ‘Good’ rating.
Located in a sought after commercial and residential suburb on an individual island site on the banks of the River Seine, Sémaphore is situated in close proximity to the centre of Paris and La Défense with excellent public transport links.
Source : Company